| ATXS Market Cap History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the ATXS market cap history going back to 8/20/2021:
Also see: ATXS Shares Outstanding History and ATXS YTD Return |
As of 10/31/2025 Astria Therapeutics has a market cap of 720.98 million. Investors often follow the ATXS market cap history to compare the size of the company over time.
This page shows ATXS market capitalization trends over time, with 17 market cap datapoints presented, dating back to 8/20/2021.

| ATXS Market Cap History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the ATXS market cap history going back to 8/20/2021:
Also see: ATXS Shares Outstanding History and ATXS YTD Return |
| ATXS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||
ATXS Historical Market Cap: +61.14% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||
| ATXS Stock Price Chart |
| About Astria Therapeutics Inc |
| Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. Co.'s lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis (AD). Co. owns two patent families directed to STAR-0215. We show 17 historical shares outstanding datapoints in our ATXS shares outstanding history coverage, used to compute ATXS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ATXS market cap history over the course of time is important for investors interested in comparing ATXS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ATXS versus a peer is one thing; comparing ATXS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ATXS can fluctuate over the course of history. With this page we aim to empower investors researching ATXS by allowing them to research the ATXS market cap history. |
| ATXS Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| ATXS Share Performance |
| Market Cap Peers |
| Astria Therapeutics (ATXS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ATYR Market Cap History AURA Market Cap History AVAH Market Cap History AVBP Market Cap History AVCO Market Cap History AVDR Market Cap History AVEO Market Cap History AVGR Market Cap History AVIR Market Cap History AVNS Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.